Investor Presentaiton
MAXIGESIC GLOBAL UPDATE
[Oral Dose Forms & IV]
Canada Tablets launched 2021
Ireland Tablets launched
IV licensed
United Kingdom - Tablets launched
IV licensed
Netherlands - IV licensed
Austria IV licensed & launched 2021
Nordics Tablets launched
IV licensed
Poland - IV and orals licensed
Eastern Europe & Balkans
-Tablets launched
Eastern Europe IV- Licensed
Iraq Kurdistan launched
Russia Orals licensed
Singapore & Brunei - Tablets launched
China licensing negotiations underway
Taiwan Tablets Licensed
Korea IV licensed
USA- IV Licensed
IV Submitted for Registration
Tablets submitted for
registration and licensing
discussions underway
Mexico - Tablets launched 2021
IV Licensed
CACM - Tablets launched
IV licensed
Pakistan -
distributor
appointed
for IV
Launched
Launch Pending
Available
Columbia, Peru, Chile -
distributor appointed Orals
IV Licensed 2021
Brazil licensing
negotiations underway
United Arab Emirates -
Tablet sales strong
Greece Orals and IV
licensed
Italy Tablet sales growing
Germany
IV Licensed
Orals Launched 2020
Germany IV Launched 2021
Switzerland Tablets licensed 2019, launched 2021
Belgium, Luxembourg- Tablets launching 2021
IV licensed July 2021
France Tablets launching 2021
IV Licensed
Spain & Portugal - Tablets launched
IV licensed
4444 444
Japan licensing
discussions
are underway
Indonesia distributor appointed for IV
NZ - Maxigesic, Maxigesic PE,
Maxigesic IV launched
Australia - No. # 1 Para-Ibu Combo.
Growing market share
Maxigesic IV launched
Philippines - AFT to sell post
registration via distributor
Malaysia Tablets launched
Thailand -
IV licensed
Vietnam distributor appointed for IV and OralsView entire presentation